These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 16176116)

  • 1. Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.
    Pea F; Viale P; Furlanut M
    Clin Pharmacokinet; 2005; 44(10):1009-34. PubMed ID: 16176116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics of antimicrobial agents in critically ill patients.
    Pea F
    Curr Clin Pharmacol; 2013 Feb; 8(1):5-12. PubMed ID: 22946868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.
    Pea F; Pavan F; Furlanut M
    Clin Pharmacokinet; 2008; 47(7):449-62. PubMed ID: 18563954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of anti-infective agents in critically ill patients.
    Jager NG; van Hest RM; Lipman J; Taccone FS; Roberts JA
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):961-79. PubMed ID: 27018631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.
    Pistolesi V; Morabito S; Di Mario F; Regolisti G; Cantarelli C; Fiaccadori E
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
    Blot S; Lipman J; Roberts DM; Roberts JA
    Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.
    Phe K; Heil EL; Tam VH
    J Infect Dis; 2020 Jul; 222(Suppl 2):S132-S141. PubMed ID: 32691832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic use in critical illness.
    Stewart SD; Allen S
    J Vet Emerg Crit Care (San Antonio); 2019 May; 29(3):227-238. PubMed ID: 31021520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancer.
    Theuretzbacher U
    Clin Infect Dis; 2012 Jun; 54(12):1785-92. PubMed ID: 22437238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy.
    Honore PM; Jacobs R; De Waele E; Spapen HD
    Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis.
    Heintz BH; Matzke GR; Dager WE
    Pharmacotherapy; 2009 May; 29(5):562-77. PubMed ID: 19397464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
    Varghese JM; Roberts JA; Lipman J
    Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.
    Fiore M; Peluso L; Taccone FS; Hites M
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.